Safety Study of GMDTC Injection in Participants With Excessive Cadmium

Clinical trial NCT06199349 · COMPLETED

Trial details

NCT number: NCT06199349
Sponsor: Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cadmium Exceeds the Standard

Start date: 2024-01-08
Primary completion: 2024-10-21
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.